Clinical Research Directory
Browse clinical research sites, groups, and studies.
Familial Breast Cancer in China
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Summary
This study is a retrospective descriptive study to collect clinical data (mainly including medical records and follow-up information, etc.) of breast cancer patients with genetic variation who were first diagnosed and treated in a number of hospitals in China during the period from January 1, 2015 to December 31, 2024, and to establish a retrospective cohort of familial hereditary breast cancer. To analyze the clinical features, diagnosis and treatment and survival prognosis of patients with familial hereditary breast cancer. To explore the main factors affecting clinical diagnosis and treatment and survival prognosis of patients
Official title: A Real-world Study of Familial Hereditary Breast Cancer in China
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2025-02-28
Completion Date
2035-02-28
Last Updated
2025-02-18
Healthy Volunteers
No
Conditions
Interventions
Genetic variation
To observe and describe the clinical features, diagnosis and treatment plan and survival prognosis of familial hereditary breast cancer in China, and explore the main factors affecting prognosis.
Locations (1)
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China